BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 30165890)

  • 1. Chitinase 3-like 1-CD44 interaction promotes metastasis and epithelial-to-mesenchymal transition through β-catenin/Erk/Akt signaling in gastric cancer.
    Geng B; Pan J; Zhao T; Ji J; Zhang C; Che Y; Yang J; Shi H; Li J; Zhou H; Mu X; Xu C; Wang C; Xu Y; Liu Z; Wen H; You Q
    J Exp Clin Cancer Res; 2018 Aug; 37(1):208. PubMed ID: 30165890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
    Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
    Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
    Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein.
    Chen Y; Zhang S; Wang Q; Zhang X
    J Hematol Oncol; 2017 Feb; 10(1):36. PubMed ID: 28143526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.
    Lu J; Bang H; Kim SM; Cho SJ; Ashktorab H; Smoot DT; Zheng CH; Ryeom SW; Yoon SS; Yoon C; Lee JH
    Oncogene; 2021 Feb; 40(5):922-936. PubMed ID: 33288885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated β-catenin in gastric cancer.
    Zhao W; Jia L; Kuai X; Tang Q; Huang X; Yang T; Qiu Z; Zhu J; Huang J; Huang W; Feng Z
    Cancer Med; 2019 Mar; 8(3):1135-1147. PubMed ID: 30632714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression.
    Wang H; Deng G; Ai M; Xu Z; Mou T; Yu J; Liu H; Wang S; Li G
    Oncogene; 2019 Feb; 38(9):1489-1507. PubMed ID: 30305727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF3 Transcription Activates WNT1 and Promotes the Growth and Metastasis of Gastric Cancer via Activation of the WNT/β-Catenin Signaling Pathway.
    Li Y; Wang Y; Zou Q; Li S; Zhang F
    Lab Invest; 2023 Jun; 103(6):100078. PubMed ID: 36827869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
    Xu M; Qin S; Cao F; Ding S; Li M
    Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
    Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
    Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer.
    Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S
    Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
    BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
    Jia S; Qu T; Wang X; Feng M; Yang Y; Feng X; Ma R; Li W; Hu Y; Feng Y; Ji K; Li Z; Jiang W; Ji J
    PLoS One; 2017; 12(4):e0175058. PubMed ID: 28422983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-inducible Protein-1 promotes metastasis of gastric cancer via Wnt/β-catenin signaling pathway.
    Huang L; Zhai E; Cai S; Lin Y; Liao J; Jin H; Peng S; Xu L; Chen M; Zeng Z
    J Exp Clin Cancer Res; 2018 Jan; 37(1):6. PubMed ID: 29335007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
    Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling.
    Gao P; Wang S; Jing F; Zhan J; Wang Y
    Cancer Biomark; 2017; 19(1):11-20. PubMed ID: 28269747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
    Li H; Piao L; Xu D; Xuan Y
    Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma.
    Qiu QC; Wang L; Jin SS; Liu GF; Liu J; Ma L; Mao RF; Ma YY; Zhao N; Chen M; Lin BY
    Sci Rep; 2018 Oct; 8(1):15029. PubMed ID: 30301907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells.
    Lin HW; Chiang YC; Sun NY; Chen YL; Chang CF; Tai YJ; Chen CA; Cheng WF
    Endocr Relat Cancer; 2019 Jan; 26(1):73-88. PubMed ID: 30121622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
    Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
    J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.